Despite a challenging year, the company has a lot to look forward to in the coming years.

High school science teachers can design tasks that not only develop students’ science skills but also change how they see ...

MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Positive Results for 8-week 48 mg Cohort in Phase 1b Trial of DA-1726 On January 5, 2026, MetaVia, Inc. (NASDAQ:MTVA) announced positive and ...

In a reminder of the money still on the table for enticing obesity assets, Corxel Pharmaceuticals has raised $287 million in ...

One of the persistent challenges in precision oncology is the fact that most advanced cancers are complex and highly individualized. A recent ...

Diabetes care is undergoing a major transformation driven by GLP-1 receptor agonists, which have expanded beyond glycemic ...

As an adjunctive treatment, empagliflozin improves glycaemic control in patients with HNF1A-related maturity-onset diabetes ...

Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...

Investing.com -- Shares of Ascendis Pharma (NASDAQ:ASND) rose as much as 8.5% to a new high. On January 20th RBC Capital updated its model based on new guidance from the company, raising its price ...

Bowery Clinic today announced expanded, physician-led protocols centered on two clinically studied peptides that act upstream ...

REMSleep Holdings, developer of the DeltaWave nasal pillow system, has received expanded 510(k) clearance from the U.S. Food ...

IPF-associated cough affects up to 80% of patients with IPF, substantially impairing their quality of life; consequently, ...